Calendar Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 193.03 USD | -0.72% |
|
+4.73% | +4.57% |
Chart calendar Charles River Laboratories International, Inc.
Upcoming events on Charles River Laboratories International, Inc.
| 2026-02-17 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 2026-05-06 | Q1 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 2026-08-11 | Q2 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 2026-11-10 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past events on Charles River Laboratories International, Inc.
| 2025-12-03 | Evercore Healthcare Conference |
| 2025-11-18 | Jefferies Global Healthcare Conference |
| 2025-11-05 | Q3 2025 Earnings Call |
| 2025-11-05 | Q3 2025 Earnings Release |
| 2025-09-10 | Baird Global Healthcare Conference |
| 2025-09-09 | Morgan Stanley Global Healthcare Conference |
| 2025-08-06 | Q2 2025 Earnings Call |
| 2025-08-06 | Q2 2025 Earnings Release |
| 2025-06-04 | Jefferies Healthcare Conference |
| 2025-06-03 | William Blair Growth Stock Conference |
| 2025-05-20 | Annual General Meeting |
| 2025-05-14 | Bank of America Global Healthcare Conference |
| 2025-05-07 | Q1 2025 Earnings Call |
| 2025-05-07 | Q1 2025 Earnings Release |
| 2025-03-12 | Barclays Global Healthcare Conference |
| 2025-02-19 | Q4 2024 Earnings Call |
| 2025-02-19 | Q4 2024 Earnings Release |
| 2025-01-14 | JP Morgan Healthcare Conference |
| 2024-12-04 | Evercore ISI HealthCONx Conference |
| 2024-11-20 | Jefferies London Healthcare Conference |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3 976 3 915 1.56% | 4 129 4 107 0.54% | 4 050 4 031 0.47% | 4 006 | 4 075 | 4 243 |
|
EBITDA Million USD | Released Forecast Spread | 991 982 0.87% | 1 013 1 017 -0.4% | 996 998 -0.19% | 967 | 982 | 1 027 |
|
EBIT Million USD | Released Forecast Spread | 834 820 1.67% | 839 842 -0.35% | 806 802 0.46% | 794 | 817 | 870 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 623 568 9.63% | 581 513 13.41% | 93,1 401 -76.8% | 312 | 485 | 559 |
|
Net income Million USD | Released Forecast Spread | 486 409 18.85% | 475 387 22.66% | 10,3 301 -96.58% | 215 | 381 | 440 |
|
EPS USD | Released Forecast Spread | 9,48 7,97 18.98% | 9,22 7,49 23.07% | 0,20 5,83 -96.57% | 4,19 | 7,22 | 9,11 |
| Announcement Date | 22/02/23 | 14/02/24 | 19/02/25 | - |
Quarterly results
| Fiscal Period | September | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1 012 993 1.82% | 1 026 1 024 0.18% | 1 010 975 3.51% | 1 003 984 1.92% | 984 942 4.48% | 1 032 990 4.3% | 1 005 991 1.42% | 987 | 999 | 1 030 | 1 024 | 1 015 | 1 033 | 1 062 | 1 060 |
|
EBITDA Million USD | Released Forecast Spread | 233 222 4.94% | 266 243 9.71% | 249 241 3.11% | 248 245 1.35% | 232 216 7.35% | 272 248 10.07% | 243 231 4.98% | 225 | 246 | 255 | 250 | 242 | 254 | 262 | 261 |
|
EBIT Million USD | Released Forecast Spread | 187 178 5.43% | 219 196 11.62% | 200 190 5.51% | 200 196 1.71% | 188 169 11.54% | 228 194 17.86% | 198 186 6.32% | 180 | 198 | 216 | 206 | 195 | 209 | 215 | 214 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 99,0 96,3 2.82% | 120 111 7.99% | 91,2 87,9 3.79% | -217 66,0 -428.29% | |||||||||||
|
Net income Million USD | Released Forecast Spread | 67,3 71,2 -5.45% | 90,0 83,9 7.32% | 68,7 78,2 -12.16% | -216 47,5 -553.65% | 25,5 45,3 -43.75% | 54,4 58,7 -7.21% | 68,6 | 102 | 92,8 | 123 | 102 | 121 | 115 | 130 | |
|
EPS USD | Released Forecast Spread | 1,30 1,35 -3.7% | 1,74 1,68 3.88% | 1,33 1,56 -14.88% | -4,22 1,19 -453.88% | 0,50 0,97 -48.45% | 1,06 1,38 -23.19% | 1,10 1,45 -23.96% | 1,36 | 1,94 | 2,00 | 2,36 | 2,14 | 2,49 | 2,36 | 2,67 |
| Announcement Date | 09/05/24 | 07/08/24 | 06/11/24 | 19/02/25 | 07/05/25 | 06/08/25 | 05/11/25 | - | - | - | - | - | - | - | - |
| 2025-12-14 | Q3 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 2026-01-21 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-01-27 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-02-02 | Q2 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-02-03 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-02-03 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-02-09 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-02-10 | Q1 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-02-11 | Q3 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-02-11 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past sector events for Charles River Laboratories International, Inc.
| 2025-12-11 | Q3 2025 Earnings Release | |
| 2025-12-10 | November 2025 Sales and Revenue Release | |
| 2025-12-10 | November 2025 Sales and Revenue Release | |
| 2025-12-09 | November 2025 Sales and Revenue Release | |
| 2025-12-09 | Q3 2025 Earnings Release | |
| 2025-11-24 | Q3 2025 Earnings Release | |
| 2025-11-21 | Q4 2025 Earnings Release | |
| 2025-11-20 | Q3 2025 Earnings Release | |
| 2025-11-19 | Q1 2026 Sales and Revenue Release - Trading Update | |
| 2025-11-17 | Q3 2025 Earnings Release (Projected) |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CRL Stock
- Calendar Charles River Laboratories International, Inc.
Select your edition
All financial news and data tailored to specific country editions
















